-
2
-
-
53649089657
-
-
The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Quality Guideline Q8 Pharmaceutical Development, 2006
-
The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Quality Guideline Q8 Pharmaceutical Development, 2006.
-
-
-
-
3
-
-
53649089191
-
-
The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Quality Guideline Q9 Quality Risk Management, 2006
-
The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Quality Guideline Q9 Quality Risk Management, 2006.
-
-
-
-
4
-
-
53649105493
-
-
The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Quality Guideline Q2(R1) Validation of Analytical Procedures: Text and Methodology, 2005
-
The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Quality Guideline Q2(R1) Validation of Analytical Procedures: Text and Methodology, 2005)
-
-
-
-
5
-
-
53649104214
-
-
24 (United States Pharmacopoeial Convention, Chapter 1225
-
USP 29-NF 24 (United States Pharmacopoeial Convention, 2006), Chapter (1225).
-
(2006)
USP 29-NF
-
-
-
6
-
-
40149110058
-
Process Robustness - A PQRI White Paper
-
Nov.-Dec
-
M. Glodek et al., "Process Robustness - A PQRI White Paper," Pharm. Eng. 26 (6), 1-11 (Nov.-Dec. 2006).
-
(2006)
Pharm. Eng
, vol.26
, Issue.6
, pp. 1-11
-
-
Glodek, M.1
-
7
-
-
53649095681
-
-
FDA 21 CFR Title Parts 210-226 (2006).
-
FDA 21 CFR Title Parts 210-226 (2006).
-
-
-
-
8
-
-
40149097469
-
FDA Perspective on the Implementation of Quality by Design
-
paper presented at the, Prague, Czech Republic, Oct
-
M. Nasr, "FDA Perspective on the Implementation of Quality by Design," paper presented at the Ninth APIC/CEFIC (Prague, Czech Republic, Oct. 2006).
-
(2006)
Ninth APIC/CEFIC
-
-
Nasr, M.1
-
9
-
-
33845238727
-
Analytical Method Transfer
-
M. Swartz and I. Krull, "Analytical Method Transfer," LC-GC 24 (11), 20-24, (2006).
-
(2006)
LC-GC
, vol.24
, Issue.11
, pp. 20-24
-
-
Swartz, M.1
Krull, I.2
-
11
-
-
0036200455
-
Analytical Method Transfer
-
S. Scypinski et al., "Analytical Method Transfer," Pharm. Technol. 26 (3), 84-88 (2002)
-
(2002)
Pharm. Technol
, vol.26
, Issue.3
, pp. 84-88
-
-
Scypinski, S.1
-
12
-
-
53649095526
-
-
PhRMA Analytical Research and Development Workshop, Wilmington, Delaware, Sept. 20, 2000.
-
PhRMA Analytical Research and Development Workshop, Wilmington, Delaware, Sept. 20, 2000.
-
-
-
-
13
-
-
40149096853
-
The Metamorphosis of Manufacturing
-
IBM report, Apr
-
"The Metamorphosis of Manufacturing," IBM report, Apr. 2005.
-
(2005)
-
-
-
14
-
-
0034037168
-
Evaluating Laboratory Performance on Quality Indicators with the Six Sigma Scale
-
D. Nevalainen et al., "Evaluating Laboratory Performance on Quality Indicators with the Six Sigma Scale," Arch. Pathol. Lab. Med. 124, 516-519 (2000).
-
(2000)
Arch. Pathol. Lab. Med
, vol.124
, pp. 516-519
-
-
Nevalainen, D.1
-
16
-
-
0003600750
-
-
ASQ Qualtiy Press, Milwaukee, WI, 2d ed
-
D. Stamatis, Failure Modes and Effects Analysis, FMEA from Theory to Execution (ASQ Qualtiy Press, Milwaukee, WI, 2d ed., 2003).
-
(2003)
Failure Modes and Effects Analysis, FMEA from Theory to Execution
-
-
Stamatis, D.1
|